医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Simavita Receives ITAC Award for “Growing an IT Company Overseas”

2015年11月27日 PM04:30
このエントリーをはてなブックマークに追加


 

SYDNEY

Simavita Limited (TSX-V:SV)(ASX:SVA), a global leader in the digital healthcare sector, is delighted to announce that it received the “Growing an IT company Overseas” award at this week’s annual Information Technology in Aged Care (ITAC) conference. The ITAC conference is the Australian aged care industry’s pre-eminent annual event for technology solutions.

The award recognises Simavita’s program to drive penetration of its Smart Incontinence Management (SIM™) system into the global digital healthcare market.

Simavita CEO, Philippa Lewis commented, “Breaking into foreign regions with a digital healthcare platform is rare, so we are very excited that Simavita’s efforts are being recognised by our peers in the Australian digital healthcare space. We are starting to see the evidence of early stage traction from our work and this award acknowledges the momentum building offshore around SIM™ as we push hard to drive our Australian developed technology into other markets.”

For further information, see our website (www.simavita.com) or contact the persons outlined below.

About Simavita

Simavita is a digital healthcare company that has developed an innovative software platform. The first application for the platform is a world first solution for the management of urinary incontinence, with a focus on the elderly. This platform technology is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.

About SIM™

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit www.simavita.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151126005553/en/

CONTACT

Company
Simavita Limited
Philippa Lewis, +61 2 8405 6381
Chief
Executive Officer
Thomas Howitt, + 61 418 351 127
Chief
Financial Officer
or
Media and Investor Relations
Jane
Lowe, +61 411 117 774
jane.lowe@irdepartment.com.au

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 中国のヘルスケア市場は今後15年間で投資と機会が急拡大の見込み
  • Dr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and Distribute DuraGen Plus® and Suturable DuraGen® Dural Regeneration in India
  • Latest clinical research confirms that IQOS reduces smoker exposure to select harmful chemicals as compared to cigarette smoke
  • 中国医疗市场将在未来15年内迎来投资热潮和诸多机遇
  • NZMP GOLD Whole Milk Powder for UHT Launches